Biotechnology company
Active 2021–2024. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2024 | INOVIO PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Termination (No Activity) |
$10,000 | |
| 2024 | INOVIO PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report (No Activity) |
$20,000 | |
| 2023 | INOVIO PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report (No Activity) |
— | |
| 2023 | INOVIO PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$50,000 | |
| 2023 | INOVIO PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | |
| 2023 | INOVIO PHARMACEUTICALS, INC. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$60,000 | |
| 2022 | INOVIO PHARMACEUTICALS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$130,000 | |
| 2022 | CORNERSTONE GOVERNMENT AFFAIRS, INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Termination |
$50,000 | |
| 2022 | INOVIO PHARMACEUTICALS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$140,000 | |
| 2022 | CORNERSTONE GOVERNMENT AFFAIRS, INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$60,000 |
| Firm | Filings | Amount |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. IN-HOUSE | 11 | $760,000 |
| CORNERSTONE GOVERNMENT AFFAIRS, INC. | 9 | $470,000 |
| Issue | Activities |
|---|---|
| Health Issues | 17 |
| Budget/Appropriations | 12 |
| Defense | 9 |
| Medical/Disease Research/Clinical Labs | 1 |